Storage of unprocessed G-CSF-mobilized whole blood in a modified Leibovitz's L15 medium preserves clonogenic capacity for at least 7 days

Bone Marrow Transplantation

Volumn 28, Issue 2, 2001, Pages 145-155

  de Kreuk, A M ^a   Jonkhoff, A R ^a   Zevenbergen, A ^a   Hendriks, E C M ^a   Schuurhuis, G J ^a   Ossenkoppele, G J ^a   Drager A M ^a   van Oostveen, J W ^a   Huijgens, P C ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cell culture media; CFU GM; Hematopoietic stem cells; Mobilized whole blood; Preservation; Transplantation

Indexed keywords

ADENINE; ANTICOAGULANT AGENT; CD34 ANTIGEN; CD38 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; CITRATE SODIUM; CITRIC ACID; GLUCOSE; GRANULOCYTE COLONY STIMULATING FACTOR; L SELECTIN; PHOSPHATE; STEM CELL FACTOR; THY 1 ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; AUTOTRANSPLANTATION; BLOOD STORAGE; BURST FORMING UNIT E; CELL CULTURE; CELL MOTILITY; CHEMOTHERAPY; CLINICAL ARTICLE; CLONOGENESIS; COLONY FORMING UNIT GM; CONTROLLED STUDY; COST; CULTURE MEDIUM; DENSITY; DRUG MEGADOSE; HUMAN; HUMAN TISSUE; METABOLISM; PH; PRIORITY JOURNAL; SERUM; STEM CELL TRANSPLANTATION; TEMPERATURE; TIME;

ADENINE; ANTIGENS, CD; ANTIGENS, CD34; BLOOD PRESERVATION; BREAST NEOPLASMS; CELL CULTURE TECHNIQUES; CITRATES; COLONY-FORMING UNITS ASSAY; CULTURE MEDIA; CULTURE MEDIA, SERUM-FREE; FEMALE; FILGRASTIM; GLUCOSE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; LYMPHOMA, NON-HODGKIN; NEOPLASMS; ORGANIC CHEMICALS; PHOSPHATES; RECOMBINANT PROTEINS; TRANSPLANTATION, AUTOLOGOUS;

EID: 0034903273     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1703127     Document Type: Article

References (53)

1. Peripheral blood progenitor cell transplantation mobilised by r-metHuG-CSF (filgrastim); a less costly alternative to autologous bone marrow transplantation
2. Costs of peripheral blood progenitor cell transplantation using whole blood mobilised by filgrastim as compared with autologous bone marrow transplantation in non-Hodgkin's lymphoma
3. Therapeutic relevance of CD34 cell dose in blood cell transplantation for cancer therapy
4. Variability and quantification of progenitor cells in venesected blood from patients receiving escalated-dose epirubicin and cyclophosphamide with G-CSF for lymphoma: Potential role in further increasing dose-intensity
5. Mobilization of peripheral blood progenitor cells (PBPC) through a combination of chemotherapy and G-CSF in breast cancer patients and a possibility of unprocessed whole blood collection
6. Stem cell factor leads to reduced blood processing during apheresis or the use of whole blood aliquots to support dose-intensive chemotherapy
7. Transplantation potential of peripheral whole blood primed by VACOP-B chemotherapy plus filgrastim (r-metHuG-CSF) in patients with aggressive non-Hodgkin's lymphoma
8. High-dose melphalan with re-infusion of unprocessed, G-CSF-primed whole blood is effective and non-toxic therapy in multiple myeloma
9. G-CSF stimulated whole blood transplantation: Clinical data of 47 relapsed NHL patients and in vitro data of prolonged storage of whole blood up to 7 days
10. Use of hematopoietic progenitors in whole blood to support dose-dense chemotherapy: A randomized phase II trial in small-cell lung cancer patients
11. G-CSF (filgrastim)-stimulated whole blood kept unprocessed at 4°C does support a BEAM-like regimen in bad-risk lymphoma
12. Viability of haemopoietic progenitors from whole blood, bone marrow and leukapheresis product: Effects of storage media, temperature and time
13. Human liquid bone marrow culture in serum-free medium
14. Nonfrozen preservation of committed hematopoietic stem cells from normal human bone marrow
15. Liquid storage of bone marrow
16. Granulocyte-macrophage progenitor cell preservation at 4°C
17. Liquid storage of unseparated human bone marrow. Evaluation of hematopoietic progenitors by clonal assay
18. Liquid storage of peripheral blood progenitor cells for transplantation
19. Role of cell shape in growth control
20. The alterations of the activities of coagulation inhibitors and fibrinolytic factors in stored cord blood could affect the yield of progenitor cells during processing
21. Reproducibility of CFU-GM enumeration in G-CSF stimulated whole blood using three different methods
22. Atlas of Human Hematopoietic Colonies
23. Mobilization of hematopoietic progenitors in patients with chronic myeloid leukemia
24. Functional characterization of individual human hematopoietic stem cells cultured at limiting dilution on supportive marrow stromal layers
25. Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis
26. The evaluation of limiting dilution assays
27. Large populations of non-clonogenic early apoptotic CD34 positive cells are present in frozen-thawed peripheral blood stem cell transplants
28. The ISHAGE guidelines for CD34+ cell determination by flow cytometry
29. The role of hypoxia in the maintenance of hematopoietic stem cells
30. Recovery of CFU-C after freezing of normal and leukemic human bone marrow
31. Postcryopreservation growth of human CFU-GM: Sequential examination of methodologic factors
32. Correlation of hematologic recovery with CFU-GM content of autologous bone marrow grafts treated with 4-hydroperoxycyclophosphamide. Culture after cryopreservation
33. Analysis of cord blood CD34+ cells purified after cryopreservation
34. Successful cryopreservation of purified autologous CD34+ cells: Influence of freezing parameters on cell recovery and engraftment
35. The cryopreservation protocol optimal for progenitor recovery is not optimal for preservation of marrow repopulating ability
36. Variations in culture pH affect the cloning efficiency and differentiation of progenitor cells in ex vivo haemopoiesis
37. Physiologically significant effects of pH and oxygen tension on granulopoiesis
38. The utilization of carbohydrates by human cell cultures
39. Metabolic inhibition of mammalian uridine diphosphate galactose 4-epimerase in cell cultures and in tumor cells
40. The growth and maintenance of tissue-cell cultures in free gas exchange with the atmosphere
41. Growth responses of cell cultures in a galactose medium
42. High density mammalian cell growth in Leibovitz bicarbonate-free medium: Effects of fructose and galactose on culture biochemistry
43. Development of an infusible-grade solution for non-cryopreserved hematopoietic cell storage
44. Expression of Thy-1 on human hematopoietic progenitor cells
45. Enrichment of human hematopoietic stem cell activity in the CD34+Thy-1+Lin- subpopulation from mobilized peripheral blood
46. low cells as primitive hematopoietic stem cells
47. Functional differences between subpopulations of mobilized peripheral blood-derived CD34+ cells expressing different levels of HLA-DR, CD33, CD38 and c-kit antigens
48. Functional characterization of a novel hematopoietic stem cell and its place in the c-Kit maturation pathway in bone marrow cell development
49. AC133, a novel marker for human hematopoietic stem and progenitor cells
50. CD34+AC133+ cells isolated from cord blood are highly enriched in long-term culture-initiating cells, NOD/SCID-repopulating cells and dendritic cell progenitors
51. Expression of adhesion molecules on CD34+ cells: CD34+ L-selectin+ cells predict a rapid platelet recovery after peripheral blood stem cell transplantation
52. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4
53. Homing of human cells in the fetal sheep model: Modulation by antibodies activating or inhibiting very late activation antigen-4-dependent function